After Long Decline, Industry Spending On CME Programs Rises Again
This article was originally published in The Gray Sheet
Drug and device companies increased funding for continuing medical education programs by 2.4 percent in 2014 to $675.9 million; support had declined steadily since peaking in 2007.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.